Td Asset Management Inc Tg Therapeutics, Inc. Transaction History

Td Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$15.48 - $35.0 $233,546 - $528,045	15,087 New	15,087 $374,000
Q3 2021 Nov 09, 2021	SELL	$21.78 - $40.45 $557,371 - $1.04 Million	-25,591 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$32.5 - $48.96 $62,270 - $93,807	-1,916 Reduced 6.97%	25,591 $895,000
Q1 2021 May 14, 2021	BUY	$41.61 - $54.3 $218,743 - $285,455	5,257 Added 23.63%	27,507 $1.33 Million
Q4 2020 Feb 16, 2021	BUY	$25.27 - $54.9 $562,257 - $1.22 Million	22,250 New	22,250 $1.16 Million

338

88.3M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.